When problems in a clinical trial are widespread, remediation becomes unavoidable. Sponsors can face inspection backlogs, recurring findings, or regulator concerns that call the reliability of trial data into question. In these situations, the cost of inaction is high, and leadership has to move quickly to protect patients and preserve programs. Meaningful remediation goes beyond fixing individual findings. It requires redesigning how trials and data flows are overseen and controlled, and how issues are detected and escalated before they reach inspectors.
HIC supports remediation as a structured change program, not a series of disconnected fixes. Experienced compliance leaders work alongside your team to map root causes, define new processes for monitoring, data management, and vendor oversight, and set up governance that tracks progress and holds owners accountable. We help implement practical controls, from new workflows and metrics to training and management routines and then perform independent verification of effectiveness so regulators see real, sustained improvement rather than promises on paper. The result is an organization that emerges from remediation with stronger systems, more efficient operations, and renewed regulator confidence.
Remediation that restores evidence integrity
- We have led large scale remediation programs after critical findings, helping sponsors stabilize trials while corrective work proceeds
- Our teams establish governance and tracking mechanisms that give leadership and regulators clear visibility into progress and risk
- We redesign oversight, monitoring, and data integrity processes so the issues behind 483s and Warning Letters do not recur in future inspections
- Independent effectiveness checks confirm that new controls work in practice, providing objective evidence to regulators of improved readiness
